Deval L. Patrick, Director at Cerevel Therapeutics Holdings, Inc. (CERE), sold 95,410 shares at $30.78 ($2.9M) on 2022-09-12, disclosed to the SEC on 2022-09-14.
Open-market sale of $2.9M CERE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.78 | 47,705 | $1.5M | 50.0% |
| 2 | $30.78 | 47,705 | $1.5M | 50.0% |
| Total | $30.78 avg | 95,410 | $2.9M | 100% |
| Filing → |
| CERE | SELL | 2023-11-03 | $753K | — | Filing → |
| AMWL | BUY | 2022-04-22 | $198K | — | Filing → |
| AMWL | SELL | 2021-11-04 | $48K | — | Filing → |